-
2023 - 01 - 02
Ibuprofen suspension – exemption to ensure supply to the population
-
2023 - 01 - 30
Stemline Therapeutics, a subsidiary of Menarini Group, Receives U.S. FDA Approval for ORSERDUTM (elacestrant) as the First and Only Treatment Specifically Indicated for Patients with ESR1 Mutations in
-
2023 - 04 - 14
The dates for the XXVII edition of the International Fair Play Menarini Awards
-
2023 - 12 - 01
BERLIN-CHEMIE: 45 years of inclusion and success for people with disabilities with the sheltered workshop